dextroamphetamine has been researched along with Cochlear Hearing Loss in 1 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tobey, EA | 1 |
| Devous, MD | 1 |
| Buckley, K | 1 |
| Overson, G | 1 |
| Harris, T | 1 |
| Ringe, W | 1 |
| Martinez-Verhoff, J | 1 |
1 trial available for dextroamphetamine and Cochlear Hearing Loss
| Article | Year |
|---|---|
Pharmacological enhancement of aural habilitation in adult cochlear implant users.
Topics: Adult; Aged; Auditory Cortex; Central Nervous System Stimulants; Cerebrovascular Circulation; Cochle | 2005 |